AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2015
Mar 2, 2015
29821_dirs_2015-03-02_aa48e956-1982-4db6-beec-5896030cbbb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-02-27
Reporting Person: Prange Karen (SVP&Pres, Uro & Women's Health)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-27 | Common Stock | S | 1307.0000 | $16.8043 | Disposed | 17430.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1000.0000 | Indirect |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 18
Capital/Financing Update
2026
May 18
Share Issue/Capital Change
2026
May 8
Major Shareholding Notification
2026
May 6
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Earnings Release
2026
Apr 22
Regulatory Filings
2026
Apr 2